
Overview
Background
Dr Clark is an Associate Professor at the School of Biomedical Sciences where he is Head of the Peptide Chemical Biology Lab. He completed his PhD in 2000 at the UQ Chemistry Department studying marine natural products chemistry and chemical ecology with Prof. Mary Garson. He then shifted his research focus towards peptide chemistry, structural biology and drug design when he was recruited to the lab of Prof. David Craik at the IMB. His current research focus is the development of technologies to stabilise peptide therapeutics and the elucidation of the structure/function activity of bioactive peptides.
Availability
- Associate Professor Richard Clark is:
- Available for supervision
Fields of research
Qualifications
- Bachelor (Honours) of Science (Advanced), University of Tasmania
- Doctor of Philosophy, The University of Queensland
Works
Search Professor Richard Clark’s works on UQ eSpace
2016
Journal Article
The N-terminal pro-domain of the kalata B1 cyclotide precursor is intrinsically unstructured
Daly, Norelle L., Gunasekera, Sunithi, Clark, Richard J., Lin, Feng, Wade, John D., Anderson, Marilyn and Craik, David J. (2016). The N-terminal pro-domain of the kalata B1 cyclotide precursor is intrinsically unstructured. Biopolymers, 106 (6), 825-833. doi: 10.1002/bip.22977
2016
Journal Article
Tick holocyclotoxins trigger host paralysis by presynaptic inhibition
Chand, Kirat K., Lee, Kah Meng, Lavidis, Nickolas A., Rodriguez-Valle, Manuel, Ijaz, Hina, Koehbach, Johannes, Clark, Richard J., Lew-Tabor, Ala and Noakes, Peter G. (2016). Tick holocyclotoxins trigger host paralysis by presynaptic inhibition. Scientific Reports, 6 (1) 29446, 29446. doi: 10.1038/srep29446
2016
Journal Article
Structure-Activity Studies of Cysteine-Rich α-Conotoxins that Inhibit High-Voltage-Activated Calcium Channels via GABAB Receptor Activation Reveal a Minimal Functional Motif
Carstens, Bodil B., Berecki, Géza, Daniel, James T., Lee, Han Siean, Jackson, Kathryn A. V., Tae, Han-Shen, Sadeghi, Mahsa, Castro, Joel, O'Donnell, Tracy, Deiteren, Annemie, Brierley, Stuart M., Craik, David J., Adams, David J. and Clark, Richard J. (2016). Structure-Activity Studies of Cysteine-Rich α-Conotoxins that Inhibit High-Voltage-Activated Calcium Channels via GABAB Receptor Activation Reveal a Minimal Functional Motif. Angewandte Chemie, 128 (15), 4770-4774. doi: 10.1002/ange.201600297
2016
Conference Publication
Development of peptide therapeutics for iron disorders
Goncalves, Daniela, Rishi, Gautam, Aliyanto, Randy, Rosengren, Johan, Subramaniam, Nathan, Frazer, David and Clark, Richard (2016). Development of peptide therapeutics for iron disorders. 6th Meeting of the International BioIron Society, Zhejiang University, Hangzhou, China, 8-10 September 2015. Hoboken, NJ, United States: John Wiley & Sons.
2016
Conference Publication
Discovery, Synthesis and Characterization of Novel Cysteine-Rich Peptides From Insects
Koehbach, J. and Clark, R. J. (2016). Discovery, Synthesis and Characterization of Novel Cysteine-Rich Peptides From Insects. HOBOKEN: WILEY.
2016
Conference Publication
Pharmacological Characterisation of the Cyclotide Kalata B7 At Insect Orthologues of the Oxytocin/vasopressin Receptors
Keov, P., Liutkeviciute, Z., Clark, R. and Gruber, C. (2016). Pharmacological Characterisation of the Cyclotide Kalata B7 At Insect Orthologues of the Oxytocin/vasopressin Receptors. HOBOKEN: WILEY.
2016
Journal Article
Structure-Activity Studies of Cysteine-Rich α-Conotoxins that Inhibit High Voltage-Activated Calcium Channels via GABAB Receptor Activation Reveal a Minimal Functional Motif
Carstens, Bodil B., Berecki, Geza, Daniel, James T., Lee, Han Siean, Jackson, Kathryn A. V., Tae, Han-Shen, Sadeghi, Mahsa, Castro, Joel, O'Donnell, Tracy, Deiteren, Annemie, Brierley, Stuart M., Craik, David J., Adams, David J. and Clark, Richard J. (2016). Structure-Activity Studies of Cysteine-Rich α-Conotoxins that Inhibit High Voltage-Activated Calcium Channels via GABAB Receptor Activation Reveal a Minimal Functional Motif. Angewandte Chemie - International Edition, 55 (15), 4692-4696. doi: 10.1002/anie.201600297
2015
Journal Article
Transforming conotoxins into cyclotides: backbone cyclization of P-superfamily conotoxins
Akcan, Muharrem, Clark, Richard J., Daly, Norelle L., Conibear, Anne C., de Faoite, Andrew, Heghinian, Mari D., Sahil, Talwar, Adams, David J., Mari, Frank and Craik, David J. (2015). Transforming conotoxins into cyclotides: backbone cyclization of P-superfamily conotoxins. Peptide Science, 104 (6), 682-692. doi: 10.1002/bip.22699
2015
Journal Article
Isolation, characterization, and synthesis of the barrettides: disulfide-containing peptides from the marine sponge Geodia barretti
Carstens, Bodil B., Rosengren, K. Johan, Gunasekera, Sunithi, Schempp, Stefanie, Bohlin, Lars, Dahlstrom, Mia, Clark, Richard J. and Goransson, Ulf (2015). Isolation, characterization, and synthesis of the barrettides: disulfide-containing peptides from the marine sponge Geodia barretti. Journal of Natural Products, 78 (8), 1886-1893. doi: 10.1021/acs.jnatprod.5b00210
2015
Journal Article
Inhibition of human prolyl oligopeptidase activity by the cyclotide psysol 2 isolated from Psychotria solitudinum
Hellinger, Roland, Koehbach, Johannes, Puigpinos, Albert, Clark, Richard J., Tarrago, Teresa, Giralt, Ernest and Gruber, Christian W. (2015). Inhibition of human prolyl oligopeptidase activity by the cyclotide psysol 2 isolated from Psychotria solitudinum. Journal of Natural Products, 78 (5), 1073-1082. doi: 10.1021/np501061t
2015
Journal Article
In vivo efficacy of anuran rypsin inhibitory peptides against Staphylococcal Skin infection and the impact of peptide cyclization
Malik, U., Silva, O. N., Fensterseifer, I. C. M., Chan, A., Clark, R. J., Franco, O. L., Daly, N. L. and Craik, D. J. (2015). In vivo efficacy of anuran rypsin inhibitory peptides against Staphylococcal Skin infection and the impact of peptide cyclization. Antimicrobial Agents and Chemotherapy, 59 (4), 2113-2121. doi: 10.1128/AAC.04324-14
2015
Journal Article
Alanine scan ofα-conotoxin regIIA reveals a selective α3β4 nicotinic acetylcholine receptor antagonist
Kompella, Shiva N., Hung, Andrew, Clark, Richard J., Mari, Frank and Adams, David J. (2015). Alanine scan ofα-conotoxin regIIA reveals a selective α3β4 nicotinic acetylcholine receptor antagonist. Journal of Biological Chemistry, 290 (2), 1039-1048. doi: 10.1074/jbc.M114.605592
2015
Conference Publication
Exploring the chemistry and pharmacological potential of bioactive peptides from insects
Koehbach, Johannes and Clark, Richard J. (2015). Exploring the chemistry and pharmacological potential of bioactive peptides from insects. 14th International Congress on Amino Acids, Peptides and Proteins, Vienna, Austria, August 3–7, 2015. Wien, Austria: Springer Wien. doi: 10.1007/s00726-015-2016-z
2014
Journal Article
Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and α-conotoxin Vc1.1 via GABAB receptor activation
Berecki, Géza, McArthur, Jeffrey R., Cuny, Hartmut, Clark, Richard J. and Adams, David J. (2014). Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and α-conotoxin Vc1.1 via GABAB receptor activation. Journal of General Physiology, 143 (4), 465-479. doi: 10.1085/jgp.201311104
2014
Conference Publication
A new target for the alpha-conotoxins: the gaba(b) receptor
Clark, R. J., Carstens, B. B., Berecki, G., Callaghan, B., Adams, D. J. and Craik, D. J. (2014). A new target for the alpha-conotoxins: the gaba(b) receptor. Oxford, United Kingdom: John Wiley & Sons.
2014
Conference Publication
Applications of conotoxins for the treatment of pain
Craik, David J., Clark, Richard J. and Poth, Aaron (2014). Applications of conotoxins for the treatment of pain. 247th National Spring Meeting of the American Chemical Society (ACS), Dallas, TX, United States, March 16-20, 2014. Washington, DC, United States: American Chemical Society.
2013
Journal Article
Erratum: Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy (Journal of Medicinal Chemistry (2011) 54 (782-787) DOI: 10.1021/jm101018r)
Akcan, Muharrem, Stroud, Mark R., Hansen, Stacey J., Clark, Richard J., Daly, Norelle L., Craik, David J. and Olson, James M. (2013). Erratum: Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy (Journal of Medicinal Chemistry (2011) 54 (782-787) DOI: 10.1021/jm101018r). Journal of Medicinal Chemistry, 56 (23), 9807-9807. doi: 10.1021/jm4016119
2013
Journal Article
Identifying key amino acid residues that affect alpha-conotoxin AuIB inhibition of alpha3beta4 nicotinic acetylcholine receptors
Grishin, Anton A., Cuny, Hartmut, Hung, Andrew, Clark, Richard J., Brust, Andreas, Akondi, Kalyana, Alewood, Paul F., Craik, David J. and Adams, David J. (2013). Identifying key amino acid residues that affect alpha-conotoxin AuIB inhibition of alpha3beta4 nicotinic acetylcholine receptors. Journal of Biological Chemistry, 288 (48), 34428-34442. doi: 10.1074/jbc.M113.512582
2013
Journal Article
Novel inhibitor cystine knot peptides from momordica charantia
He, Wen-Jun, Chan, Lai Yue, Clark, Richard J., Tang, Jun, Zeng, Guang-Zhi, Franco, Octavio L., Cantacessi, Cinzia, Craik, David J., Daly, Norelle L. and Tan, Ning-Hua (2013). Novel inhibitor cystine knot peptides from momordica charantia. PLoS ONE, 8 (10) e75334, e75334.1-e75334.10. doi: 10.1371/journal.pone.0075334
2013
Journal Article
Design, synthesis and characterisation of cyclic analogues of the iron regulatory peptide hormone hepcidin
Clark, Richard J., Preza, Gloria C., Tan, Chia Chia, van Dijk, Johannes W. A., Fung, Eileen, Nemeth, Elizabeta, Ganz, Tomas and Craik, David J. (2013). Design, synthesis and characterisation of cyclic analogues of the iron regulatory peptide hormone hepcidin. Biopolymers: Peptide Science, 100 (5), 519-526. doi: 10.1002/bip.22350
Funding
Current funding
Past funding
Supervision
Availability
- Associate Professor Richard Clark is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Design and development of peptide ligands targeting the complement system
Principal Advisor
Other advisors: Professor Trent Woodruff
-
Doctor Philosophy
Making peptide drugs orally bioavailable
Principal Advisor
Other advisors: Associate Professor Johan Rosengren
-
Master Philosophy
Preclinical evaluation of C3a agonist drugs for treatment MND/ALS.
Associate Advisor
Other advisors: Dr John Lee, Dr Vinod Kumar, Professor Trent Woodruff
-
Doctor Philosophy
Novel long-acting and orally delivered conotoxin-based peptides with both analgesic efficacy and disease modifying potential
Associate Advisor
Other advisors: Dr Andy Kuo, Emeritus Professor Maree Smith
Completed supervision
-
2022
Doctor Philosophy
Design and Development of Peptides Targeting the C5a-C5aR Interaction
Principal Advisor
Other advisors: Professor Trent Woodruff, Associate Professor Johan Rosengren
-
2020
Doctor Philosophy
Development of miniaturised alpha-conotoxins for the treatment of pain
Principal Advisor
Other advisors: Associate Professor Johan Rosengren
-
2019
Doctor Philosophy
Mining helminth secretions for new classes of immune suppressing drugs
Principal Advisor
Other advisors: Associate Professor Johan Rosengren
-
2018
Doctor Philosophy
Development of Peptide Therapeutics for Iron Disorders
Principal Advisor
Other advisors: Associate Professor Johan Rosengren
-
2014
Doctor Philosophy
Marine natural wonders and the beginning of their journey towards the pharmaceutical market
Principal Advisor
Other advisors: Professor David Craik
-
2024
Master Philosophy
The Structural and Functional Role of Post-translational Modification in the µ-Conotoxins
Associate Advisor
Other advisors: Dr Anne Conibear, Associate Professor Johan Rosengren
-
2024
Doctor Philosophy
A novel cyclic peptide scaffold for drug design applications
Associate Advisor
Other advisors: Associate Professor Johan Rosengren
-
2022
Doctor Philosophy
Preclinical development of complement C5aR1 antagonists for the treatment of inflammatory bowel disease
Associate Advisor
Other advisors: Dr John Lee, Dr Vinod Kumar, Dr Felicity Han, Professor Trent Woodruff
-
2022
Doctor Philosophy
Structural Studies of Peptides Buried within Seed Storage Proteins
Associate Advisor
Other advisors: Associate Professor Johan Rosengren
-
2021
Doctor Philosophy
Investigating the Immunopharmacology of the Complement C5a Receptors, C5aR1 and C5aR2
Associate Advisor
Other advisors: Dr John Lee, Professor Mark Blaskovich, Professor Trent Woodruff
-
2020
Doctor Philosophy
Targeting of relaxin-3 analogues to the brain for pharmacological modulation of neurosignalling
Associate Advisor
Other advisors: Associate Professor Johan Rosengren
-
2019
Doctor Philosophy
Expanding the Structural Atlas of Peptide Toxins
Associate Advisor
Other advisors: Associate Professor Johan Rosengren
-
2017
Doctor Philosophy
Structural insights into cyclic plant peptides and their albumin precursors
Associate Advisor
Other advisors: Associate Professor Johan Rosengren
-
2015
Doctor Philosophy
The Science and Business of Novel Therapeutics: The Need for a Complete Picture
Associate Advisor
Other advisors: Professor Damian Hine, Professor David Craik
-
2012
Doctor Philosophy
PEPLINK: A Fragment-Based Method for Screening Peptides as Drug Leads
Associate Advisor
Other advisors: Professor David Craik
-
2011
Doctor Philosophy
Design and discovery of cyclic peptides with applications in drug development
Associate Advisor
Other advisors: Professor David Craik
-
2010
Doctor Philosophy
The story of a-conotoxins, Vc1.1 and RgIA, on their journey to becoming therapeutics
Associate Advisor
Other advisors: Professor David Craik
Media
Enquiries
For media enquiries about Associate Professor Richard Clark's areas of expertise, story ideas and help finding experts, contact our Media team: